New Jersey Supreme Court Denies Centralized Management for NexGen Flex Products Claims

In a decision apparently made last month but only published at the end of last week, the New Jersey Supreme Court has denied an application for centralized management of all pending state court claims involving certain NexGen Flex knee replacement products.  We noted the pendency of this application earlier this year.

Unlike many applications for centralized management or mass tort status in New Jersey that are submitted by plaintiffs — who often seek the procedural and other benefits of coordinated proceedings — the NexGen application was submitted on behalf of the defendants.

In rejecting the application, the New Jersey Supreme Court provided no reasons for its decision.  As a result, practioners in this area can glean no guidance from the Court’s action that might inform future applications for centralization.

Leave a Reply

Next ArticleNew Jersey Mass Tort Court Rejects Brand-Name Liability for Generic Drugs